The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.
暂无分享,去创建一个
N Woodford | G Kahlmeter | F M Aarestrup | R Canton | F. Aarestrup | M. Mulvey | H. Hasman | T. Peto | J. Rolain | N. Woodford | K. Hopkins | T. Naas | A. MacGowan | M. Holden | C. Köser | M. Ellington | J. Iredell | Ø. Samuelsen | G. Kahlmeter | R. Cantón | M. Doumith | C. Giske | D. Mevius | M. Ellington | T Naas | O. Ekelund | H. Grundman | A MacGowan | D Mevius | M J Ellington | O Ekelund | M Doumith | C Giske | H Grundman | H Hasman | M T G Holden | K L Hopkins | J Iredell | C U Köser | M Mulvey | T Peto | J-M Rolain | Ø Samuelsen | A. Macgowan | Tim E. A. Peto | Rafael Cantón | Henrik Hasman | Matthew T. G. Holden | Dik Mevius | M. Mulvey | Thierry Naas | T. E. A. Peto | Ørjan Samuelsen | Henrik Hasman | Dik J. Mevius | M. R. Mulvey | Matthew T G Holden
[1] M. Unemo,et al. Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone , 2011, Antimicrobial Agents and Chemotherapy.
[2] M. Jevons,et al. Cellbenin-resistant staphylococci. , 1961 .
[3] Yongfei Hu,et al. Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants , 2014, BMC Genomics.
[4] Jon W. Weeks,et al. AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening , 2010, Molecular microbiology.
[5] B. Kreiswirth,et al. Mutations of the ompK36 Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin , 2013, Antimicrobial Agents and Chemotherapy.
[6] A. Tomasz,et al. Novel Determinants of Antibiotic Resistance: Identification of Mutated Loci in Highly Methicillin-Resistant Subpopulations of Methicillin-Resistant Staphylococcus aureus , 2014, mBio.
[7] S. Rasmussen,et al. Identification of acquired antimicrobial resistance genes , 2012, The Journal of antimicrobial chemotherapy.
[8] K. Holmes,et al. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] H. Chambers,et al. Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. , 1999, The Journal of infectious diseases.
[10] Yoshiaki Kawamura,et al. Emergence and Spread of Neisseria gonorrhoeae Clinical Isolates Harboring Mosaic-Like Structure of Penicillin-Binding Protein 2 in Central Japan , 2005, Antimicrobial Agents and Chemotherapy.
[11] P. Bradford,et al. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. , 2007, Microbial drug resistance.
[12] Y. Shamoo,et al. The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility , 2015, Antimicrobial Agents and Chemotherapy.
[13] Jianzhong Shen,et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. , 2015, The Lancet. Infectious diseases.
[14] J. Rolain,et al. Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter , 2013, Expert review of anti-infective therapy.
[15] Yhu-Chering Huang,et al. Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia. , 2015, The Journal of antimicrobial chemotherapy.
[16] S. Niemann,et al. Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients , 2013, PloS one.
[17] L. Ng,et al. Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae , 2002, Antimicrobial Agents and Chemotherapy.
[18] P. Ruggerone,et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity , 2015, Proceedings of the National Academy of Sciences.
[19] A. Adesokan,et al. Next-Generation Sequencing for Typing and Detection of Resistance Genes: Performance of a New Commercial Method during an Outbreak of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli , 2014, Journal of Clinical Microbiology.
[20] N. Woodford,et al. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. , 2011, FEMS microbiology reviews.
[21] G. Horsman,et al. Whole-Genome Phylogenomic Heterogeneity of Neisseria gonorrhoeae Isolates with Decreased Cephalosporin Susceptibility Collected in Canada between 1989 and 2013 , 2014, Journal of Clinical Microbiology.
[22] Steven D. Dallas,et al. Comparative Whole Genome Sequencing of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Sequence Type 8 from Primary Care Clinics in a Texas Community , 2015, Pharmacotherapy.
[23] Phelim Bradley,et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study , 2015, The Lancet. Infectious diseases.
[24] F. Cobelens,et al. End TB with precision treatment! , 2016, European Respiratory Journal.
[25] Katsuhisa Endo,et al. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[26] S. Borrell,et al. KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes , 2014, BMC Genomics.
[27] Akifumi Yamashita,et al. TGS-TB: Total Genotyping Solution for Mycobacterium tuberculosis Using Short-Read Whole-Genome Sequencing , 2015, PloS one.
[28] J. Posey,et al. Disparities in Capreomycin Resistance Levels Associated with the rrs A1401G Mutation in Clinical Isolates of Mycobacterium tuberculosis , 2014, Antimicrobial Agents and Chemotherapy.
[29] J. Leeds,et al. In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin. , 2014, The Journal of antimicrobial chemotherapy.
[30] N. Dendukuri,et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults , 2014, The Cochrane database of systematic reviews.
[31] H. McIlleron,et al. Serum drug concentrations predictive of pulmonary tuberculosis outcomes. , 2013, The Journal of infectious diseases.
[32] Sharon J. Peacock,et al. Whole-genome sequencing to control antimicrobial resistance , 2014, Trends in genetics : TIG.
[33] Carlos Juan,et al. The increasing threat of Pseudomonas aeruginosa high-risk clones. , 2015, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[34] Tyson A. Clark,et al. Whole-Genome Assembly of Klebsiella pneumoniae Coproducing NDM-1 and OXA-232 Carbapenemases Using Single-Molecule, Real-Time Sequencing , 2014, Antimicrobial Agents and Chemotherapy.
[35] M. Pallen,et al. Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer , 2014, PeerJ.
[36] Alessandra Carattoli,et al. Characterization and PCR-Based Replicon Typing of Resistance Plasmids in Acinetobacter baumannii , 2010, Antimicrobial Agents and Chemotherapy.
[37] Jukka Corander,et al. Evolution and transmission of drug resistant tuberculosis in a Russian population , 2014, Nature Genetics.
[38] Kenneth D. Doig,et al. Decreased Vancomycin Susceptibility in Staphylococcus aureus Caused by IS256 Tempering of WalKR Expression , 2013, Antimicrobial Agents and Chemotherapy.
[39] D. Andersson,et al. Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium , 2009, Antimicrobial Agents and Chemotherapy.
[40] Samuel A. Assefa,et al. Elucidating Emergence and Transmission of Multidrug-Resistant Tuberculosis in Treatment Experienced Patients by Whole Genome Sequencing , 2013, PloS one.
[41] P. Barry,et al. The use of cephalosporins for gonorrhea: the impending problem of resistance , 2009 .
[42] P. Courtin,et al. Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile. , 2013, Microbiology.
[43] L. Rigouts,et al. Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations , 2013, Journal of Clinical Microbiology.
[44] D. Dowdy,et al. The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model , 2015, The Lancet. Respiratory medicine.
[45] S. Amyes,et al. Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins. , 2012, Journal of medical microbiology.
[46] S. Partridge,et al. Analysis of antibiotic resistance regions in Gram-negative bacteria. , 2011, FEMS microbiology reviews.
[47] Timothy B. Stockwell,et al. SISPA-Seq for rapid whole genome surveys of bacterial isolates. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[48] G Kahlmeter,et al. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[49] J. Blanco,et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.
[50] M. Unemo,et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[51] M. Galas,et al. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[52] Nalin Rastogi,et al. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage , 2015, Nature Genetics.
[53] Daniel J. Wilson,et al. Prediction of Staphylococcus aureus Antimicrobial Resistance by Whole-Genome Sequencing , 2014, Journal of Clinical Microbiology.
[54] L. Rigouts,et al. Specific gyrA gene mutations predict poor treatment outcome in MDR-TB , 2015, The Journal of antimicrobial chemotherapy.
[55] N. Loman,et al. Twenty years of bacterial genome sequencing , 2015, Nature Reviews Microbiology.
[56] Whole genome sequencing of penicillin-resistant Streptococcus pneumoniae reveals mutations in penicillin-binding proteins and in a putative iron permease , 2011, Genome Biology.
[57] Daniel J. Wilson,et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study , 2013, The Lancet. Infectious diseases.
[58] Stephen D. Bentley,et al. Microevolution of extensively drug-resistant tuberculosis in Russia. , 2012, Genome research.
[59] Marco Schito,et al. Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] M. Kaufmann,et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.
[61] Shaohua Zhao,et al. WGS accurately predicts antimicrobial resistance in Escherichia coli. , 2015, The Journal of antimicrobial chemotherapy.
[62] P HAUDUROY,et al. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. , 1963, Bulletin of the World Health Organization.
[63] Thomas Bo Schön,et al. Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing , 2011, Antimicrobial Agents and Chemotherapy.
[64] M. Unemo,et al. Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.
[65] T. Peláez,et al. Metronidazole Resistance in Clostridium difficile Is Heterogeneous , 2008, Journal of Clinical Microbiology.
[66] Jeffrey D Klausner,et al. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. , 2012, Microbial drug resistance.
[67] Stefan Niemann,et al. Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological Study , 2013, PLoS medicine.
[68] Sonia Cárdenas-Brito,et al. Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species , 2015, BMC Genomics.
[69] P. Stefanelli,et al. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. , 2009, The Journal of antimicrobial chemotherapy.
[70] I. Martin,et al. Azithromycin Resistance Is Coevolving with Reduced Susceptibility to Cephalosporins in Neisseria gonorrhoeae in Ontario, Canada , 2014, Antimicrobial Agents and Chemotherapy.
[71] E. Snesrud,et al. IS5 Element Integration, a Novel Mechanism for Rapid In Vivo Emergence of Tigecycline Nonsusceptibility in Klebsiella pneumoniae , 2014, Antimicrobial Agents and Chemotherapy.
[72] C. del Rio,et al. Population structure of Neisseria gonorrhoeae based on whole genome data and its relationship with antibiotic resistance , 2015, PeerJ.
[73] Fernando de la Cruz,et al. Plasmid Flux in Escherichia coli ST131 Sublineages, Analyzed by Plasmid Constellation Network (PLACNET), a New Method for Plasmid Reconstruction from Whole Genome Sequences , 2014, PLoS genetics.
[74] Y. Doi,et al. Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacterbaumannii Infections , 2014, Drugs.
[75] Johan W Mouton,et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. , 2003, The Journal of antimicrobial chemotherapy.
[76] K. Sankar,et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[77] H. Giamarellou,et al. Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches , 2014, Expert opinion on pharmacotherapy.
[78] Tim E A Peto,et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study , 2014, The Lancet. Respiratory medicine.
[79] Magnus Unemo,et al. Genetics of Chromosomally Mediated Intermediate Resistance to Ceftriaxone and Cefixime in Neisseria gonorrhoeae , 2009, Antimicrobial Agents and Chemotherapy.
[80] John W. Tapsall,et al. Diversity of penA Alterations and Subtypes in Neisseria gonorrhoeae Strains from Sydney, Australia, That Are Less Susceptible to Ceftriaxone , 2007, Antimicrobial Agents and Chemotherapy.
[81] H. Tettelin,et al. Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae , 2015, Front. Microbiol..
[82] A Stary,et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[83] Jolyon Holdstock,et al. Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples , 2015, Journal of Clinical Microbiology.
[84] P. A. Rolfe,et al. Rapid Resistome Fingerprinting and Clonal Lineage Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates by Targeted Next-Generation Sequencing , 2014, Journal of Clinical Microbiology.
[85] S. Chisholm,et al. High-Level Azithromycin Resistance Occurs in Neisseria gonorrhoeae as a Result of a Single Point Mutation in the 23S rRNA Genes , 2010, Antimicrobial Agents and Chemotherapy.
[86] N. Woodford,et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. , 2009, The Journal of antimicrobial chemotherapy.
[87] A. Carattoli,et al. Genomics of KPC-Producing Klebsiella pneumoniae Sequence Type 512 Clone Highlights the Role of RamR and Ribosomal S10 Protein Mutations in Conferring Tigecycline Resistance , 2013, Antimicrobial Agents and Chemotherapy.
[88] Thomas R Rogers,et al. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study , 2016, The Lancet. Respiratory medicine.
[89] L. Rigouts,et al. Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis? , 2013, Journal of Clinical Microbiology.
[90] Ying Zhang,et al. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.
[91] L. Bry,et al. Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System , 2015, mBio.
[92] C. Robert,et al. Real-Time Sequencing To Decipher the Molecular Mechanism of Resistance of a Clinical Pan-Drug-Resistant Acinetobacter baumannii Isolate from Marseille, France , 2012, Antimicrobial Agents and Chemotherapy.
[93] P. Beckert,et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. , 2015, The New England journal of medicine.
[94] S. Niemann,et al. Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study , 2014, mBio.
[95] Jacques Corbeil,et al. The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility , 2014, Antimicrobial Agents and Chemotherapy.
[96] S. Rasmussen,et al. Meta-genomic analysis of toilet waste from long distance flights; a step towards global surveillance of infectious diseases and antimicrobial resistance , 2015, Scientific Reports.
[97] R. Kaas,et al. Genomic Dissection of Travel-Associated Extended-Spectrum-Beta-Lactamase-Producing Salmonella enterica Serovar Typhi Isolates Originating from the Philippines: a One-Off Occurrence or a Threat to Effective Treatment of Typhoid Fever? , 2014, Journal of Clinical Microbiology.
[98] S. Borrell,et al. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. , 2013, Trends in genetics : TIG.
[99] F. Aarestrup,et al. Extremely Drug-Resistant Salmonella enterica Serovar Senftenberg Infections in Patients in Zambia , 2012, Journal of Clinical Microbiology.
[100] V. di Pilato,et al. MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin , 2014, Antimicrobial Agents and Chemotherapy.
[101] J. Vila,et al. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace , 2012, Front. Microbio..
[102] M. Arendrup,et al. Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species , 2009, Antimicrobial Agents and Chemotherapy.
[103] M. Touchon,et al. The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences , 2014, Genome biology and evolution.
[104] Harald Seifert,et al. Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.
[105] E. Marcotte,et al. Intrinsic Antimicrobial Resistance Determinants in the Superbug Pseudomonas aeruginosa , 2015, mBio.
[106] Enrico W. Coiera,et al. Context-driven discovery of gene cassettes in mobile integrons using a computational grammar , 2009, BMC Bioinformatics.
[107] Phelim Bradley,et al. Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis , 2015, Nature Communications.
[108] Julian Parkhill,et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. , 2012, The New England journal of medicine.
[109] V. Sintchenko,et al. Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis. , 2015, The Journal of antimicrobial chemotherapy.
[110] Andrew C. Pawlowski,et al. The Comprehensive Antibiotic Resistance Database , 2013, Antimicrobial Agents and Chemotherapy.
[111] Kelly P. Williams,et al. Resistance Determinants and Mobile Genetic Elements of an NDM-1-Encoding Klebsiella pneumoniae Strain , 2014, PloS one.
[112] P. Ashton,et al. MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island , 2014, Nature Biotechnology.
[113] P. Bradford,et al. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli. , 2007, The Journal of antimicrobial chemotherapy.
[114] P. Beckert,et al. PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data , 2015, Journal of Clinical Microbiology.
[115] J. Pagés,et al. Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region. , 2002, The Biochemical journal.
[116] T. Kirikae,et al. CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): A publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates. , 2015, Tuberculosis.
[117] M. Fukuda,et al. An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus , 2010, Antimicrobial Agents and Chemotherapy.
[118] Mark A. Miller,et al. Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole , 2014, PloS one.
[119] G. Kahlmeter,et al. Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. , 2012, Bulletin of the World Health Organization.
[120] G. Kahlmeter,et al. The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement? , 2015, The Journal of antimicrobial chemotherapy.
[121] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[122] M. Iacono,et al. The genomics of Acinetobacter baumannii: Insights into genome plasticity, antimicrobial resistance and pathogenicity , 2011, IUBMB life.
[123] P. Leprohon,et al. Genomic Characterization of Ciprofloxacin Resistance in a Laboratory-Derived Mutant and a Clinical Isolate of Streptococcus pneumoniae , 2013, Antimicrobial Agents and Chemotherapy.
[124] P. de Rijk,et al. Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis , 2016, The Journal of antimicrobial chemotherapy.
[125] J. Shetty,et al. Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus , 2003, Science.
[126] J. R. Johnson,et al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data , 2013, The Journal of antimicrobial chemotherapy.
[127] Ole Lund,et al. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. , 2013, The Journal of antimicrobial chemotherapy.
[128] Julian Parkhill,et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic , 2013, Genome research.
[129] B. Olsen,et al. Antimicrobial susceptibility in Escherichia coli of human and avian origin--a comparison of wild-type distributions. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[130] Julian Parkhill,et al. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study , 2014, The Lancet. Infectious diseases.
[131] N. Woodford,et al. Rapid Detection and Estimation by Pyrosequencing of 23S rRNA Genes with a Single Nucleotide Polymorphism Conferring Linezolid Resistance in Enterococci , 2003, Antimicrobial Agents and Chemotherapy.
[132] I. Martin,et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.
[133] R. Hakenbeck. Discovery of β-lactam-resistant variants in diverse pneumococcal populations , 2014, Genome Medicine.
[134] M. Martí-Renom,et al. Impact of fgd1 and ddn Diversity in Mycobacterium tuberculosis Complex on In Vitro Susceptibility to PA-824 , 2011, Antimicrobial Agents and Chemotherapy.
[135] Ole Lund,et al. In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing , 2014, Antimicrobial Agents and Chemotherapy.
[136] J. Rolain,et al. ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes , 2013, Antimicrobial Agents and Chemotherapy.
[137] M. Unemo,et al. High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.
[138] G. Smith,et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. , 2013, The New England journal of medicine.
[139] S. Niemann,et al. Importance of the Genetic Diversity within the Mycobacterium tuberculosis Complex for the Development of Novel Antibiotics and Diagnostic Tests of Drug Resistance , 2012, Antimicrobial Agents and Chemotherapy.
[140] A. Gales,et al. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy , 2010, Expert review of anti-infective therapy.
[141] C. Furusawa,et al. Prediction of antibiotic resistance by gene expression profiles , 2014, Nature Communications.
[142] M. Unemo,et al. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.
[143] Francesc Coll,et al. Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences , 2015, Genome Medicine.
[144] Lutz Wiehlmann,et al. Pseudomonas aeruginosa Genomic Structure and Diversity , 2011, Front. Microbio..
[145] L. Rigouts,et al. Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods , 2013, Journal of Clinical Microbiology.
[146] Nancy D. Hanson,et al. Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms , 2009, Clinical Microbiology Reviews.
[147] S. Huhulescu,et al. Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. , 2008, Journal of medical microbiology.
[148] Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae. , 2013, International journal of antimicrobial agents.
[149] Razvan Sultana,et al. Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis , 2013, Nature Genetics.
[150] P. Leprohon,et al. Genomic Analyses of DNA Transformation and Penicillin Resistance in Streptococcus pneumoniae Clinical Isolates , 2013, Antimicrobial Agents and Chemotherapy.
[151] F. Balloux,et al. Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain , 2015, Nature Communications.
[152] Thomas Abeel,et al. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal , 2015, PLoS medicine.
[153] Mark A. Miller,et al. Characterization of a Stable, Metronidazole-Resistant Clostridium difficile Clinical Isolate , 2013, PloS one.
[154] Jonas Korlach,et al. Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae , 2014, Science Translational Medicine.
[155] J. Rolain,et al. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. , 2012, International journal of antimicrobial agents.
[156] P. Bradford,et al. Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae , 2005, Antimicrobial Agents and Chemotherapy.
[157] Andrew Clayphan,et al. Computational inference of grammars for larger-than-gene structures from annotated gene sequences , 2011, Bioinform..
[158] M. Pallen,et al. Whole-Genome Sequencing for Rapid Susceptibility Testing of M. tuberculosis , 2013 .
[159] P. Nordmann,et al. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. , 2015, International journal of antimicrobial agents.
[160] P. Leprohon,et al. Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae. , 2013, The Journal of antimicrobial chemotherapy.
[161] S. Chisholm,et al. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[162] A P MacGowan,et al. EUCAST expert rules in antimicrobial susceptibility testing. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[163] Dongfang Li,et al. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance , 2013, Nature Genetics.
[164] H. Palmer,et al. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. , 2008, The Journal of antimicrobial chemotherapy.
[165] R. Knox,et al. “Celbenin” - resistant Staphylococci , 1961 .
[166] T. Sterling,et al. High Proportion of Heteroresistance in gyrA and gyrB in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical Isolates , 2014, Antimicrobial Agents and Chemotherapy.
[167] S. Pournaras,et al. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. , 2013, International journal of antimicrobial agents.
[168] G. Kahlmeter,et al. Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections , 2010, Journal of Clinical Microbiology.
[169] A. Weintraub,et al. Antimicrobial resistance in Clostridium difficile. , 2009, International journal of antimicrobial agents.
[170] G. Dougan,et al. Routine Use of Microbial Whole Genome Sequencing in Diagnostic and Public Health Microbiology , 2012, PLoS pathogens.
[171] P. Klatser,et al. Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance , 2009, The Journal of antimicrobial chemotherapy.
[172] H. Gingras,et al. Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing. , 2015, The Journal of antimicrobial chemotherapy.
[173] J. Vázquez,et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. , 2009, Sexually transmitted diseases.
[174] K. Ko,et al. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance. , 2014, The Journal of antimicrobial chemotherapy.
[175] A. Witney,et al. High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom , 2015, Journal of Clinical Microbiology.
[176] Rene S. Hendriksen,et al. DANMAP 2016 - Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark , 2017 .
[177] F. Balloux,et al. Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient , 2014, Genome Biology.
[178] R. Hancock,et al. Pseudomonas aeruginosa: all roads lead to resistance. , 2011, Trends in microbiology.
[179] Daniel J. Wilson,et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance , 2012, BMJ Open.
[180] Paolo Visca,et al. Acinetobacter baumannii: evolution of a global pathogen. , 2014, Pathogens and disease.
[181] Jukka Corander,et al. Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe , 2016, mBio.
[182] M. Daffé,et al. Clinical characteristics of the smooth tubercle bacilli 'Mycobacterium canettii' infection suggest the existence of an environmental reservoir. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[183] G. Kronvall. Normalized Resistance Interpretation as a Tool for Establishing Epidemiological MIC Susceptibility Breakpoints , 2010, Journal of Clinical Microbiology.
[184] E. Böttger. The ins and outs of Mycobacterium tuberculosis drug susceptibility testing. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[185] Justin Zobel,et al. SRST2: Rapid genomic surveillance for public health and hospital microbiology labs , 2014 .
[186] Serge Morand,et al. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..
[187] J. Kop,et al. Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay , 2010, Journal of Clinical Microbiology.
[188] James E. Galagan,et al. Genomic insights into tuberculosis , 2014, Nature Reviews Genetics.
[189] S. Niemann,et al. Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid. , 2013, The Journal of antimicrobial chemotherapy.
[190] S. Cole,et al. The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis , 1992, Nature.